BRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China

Reuters03-10

March 9 (Reuters) - HUTCHMED (China) Ltd 0013.HK:

IPSEN INITIATES MARKET WITHDRAWAL AND RECALL OF TAZVERIK IN CHINA
WITHDRAWS AND RECALLS TAZVERIK IN CHINA, HONG KONG, MACAU; ENDS ALL CLINICAL TRIALS
ІPSEN HAS INFORMED HUTCHMED THAT IT IS VOLUNTARILY WITHDRAWING TAZVERІK IN US

Further company coverage: 0013.HK

((Reuters.Briefs@thomsonreuters.com;))

At the request of the copyright holder, you need to log in to view this content

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2618673716?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-03-10 01:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2618673716","market":"nz","top_or_hot":-1,"title":"BRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China</title></head><body><p><span>March 9 (Reuters)</span><span> - </span>HUTCHMED (China) Ltd <span>0013.HK</span>:</p><ul><li><p>IPSEN INITIATES MARKET WITHDRAWAL AND RECALL OF TAZVERIK IN CHINA</p></li><li><p>WITHDRAWS AND RECALLS TAZVERIK IN CHINA, HONG KONG, MACAU; ENDS ALL CLINICAL TRIALS</p></li><li><p>ІPSEN HAS INFORMED HUTCHMED THAT IT IS VOLUNTARILY WITHDRAWING TAZVERІ<a href=\"https://laohu8.com/S/TKKD.SI\">K</a> IN US</p></li></ul><p>Further company coverage: <span>0013.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2026-03-10 01:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\"><head><title>BRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In China</title></head><body><p><span>March 9 (Reuters)</span><span> - </span>HUTCHMED (China) Ltd <span>0013.HK</span>:</p><ul><li><p>IPSEN INITIATES MARKET WITHDRAWAL AND RECALL OF TAZVERIK IN CHINA</p></li><li><p>WITHDRAWS AND RECALLS TAZVERIK IN CHINA, HONG KONG, MACAU; ENDS ALL CLINICAL TRIALS</p></li><li><p>ІPSEN HAS INFORMED HUTCHMED THAT IT IS VOLUNTARILY WITHDRAWING TAZVERІ<a href=\"https://laohu8.com/S/TKKD.SI\">K</a> IN US</p></li></ul><p>Further company coverage: <span>0013.HK</span></p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"00013","symbol_name":"和黄医药","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260309:nFWN3ZX0ME:1","article_id":"2618673716","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2618673716","pubTimestamp":1773076343,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"BRIEF-Hutchmed  Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In ChinaMarch 9  - HUTCHMED  Ltd 0013.HK:IPSEN INITIATES MARKET WITHDRAWAL AND RECALL OF TAZVERIK IN CHINAWITHDRAWS AND RECALLS TAZVERIK IN CHINA, HONG KONG, MACAU; ENDS ALL CLINICAL TRIALSPSEN HAS INFORMED HUTCHMED THAT IT IS VOLUNTARILY WITHDRAWING TAZVERK IN USFurther company coverage: 0013.HK ","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"00013":"和黄医药","BK1587":"次新股","BK1588":"回港中概股","BK1191":"制药"},"translate_title":"简介-和黄医药（中国）表示益普生在中国开始召回Tazverik","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"00013":0.9},"content_text":"BRIEF-Hutchmed (China) Says Ipsen Initiates Market Withdrawal And Recall Of Tazverik In ChinaMarch 9 (Reuters) - HUTCHMED (China) Ltd 0013.HK:IPSEN INITIATES MARKET WITHDRAWAL AND RECALL OF TAZVERIK IN CHINAWITHDRAWS AND RECALLS TAZVERIK IN CHINA, HONG KONG, MACAU; ENDS ALL CLINICAL TRIALSІPSEN HAS INFORMED HUTCHMED THAT IT IS VOLUNTARILY WITHDRAWING TAZVERІK IN USFurther company coverage: 0013.HK ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":true,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2618673716","isCrawlerRequest":true}